In addition to being a biomarker of cardiovascular risk and proposed clinical marker to guide treatment for cardiovascular disease events,2,3 elevated CRP is a significant predictor for future diagnosis of metabolic syndrome and type 2 diabetes.2 This evidence concerns the gene CRP and metabolic syndrome.